Meritain Eldorado policies

Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

36 policies name 97814, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Meritain Eldorado policies
PolicyDetailsCodesSource
0302-Xerostomia: Selected Treatments0302 · Commercial10Original policy ↗
0676-Electrical Stimulation for Nausea, Vomiting and Motion Sickness (PrimaBella and ReliefBand) and Other Selected Indications0676 · Commercial17Original policy ↗
Enuresis0431 · Commercial19Original policy ↗
0665-Constraint-Induced Therapy0665 · Commercial20Original policy ↗
Hyperhidrosis0504 · Commercial26Original policy ↗
0852-Neurogenic Bladder: Selected Treatments0852 · Commercial27Original policy ↗
0304-Fibroid Treatment0304 · Commercial29Original policy ↗
0135-Acupuncture and Dry Needling0135 · Commercial30Original policy ↗
Dry Eyes0457 · Commercial36Original policy ↗
0789-Acute Ischemic Stroke: Treatments0789 · Commercial40Original policy ↗
0732-Guillain-Barre Syndrome Treatments0732 · Commercial43Original policy ↗
0625-Dysphagia Therapy0625 · Commercial44Original policy ↗
Weight Reduction Programs and Devices0039 · Commercial46Original policy ↗
0235-Plantar Fasciitis Treatments0235 · Commercial48Original policy ↗
0812-Hypoxic Ischemic Encephalopathy0812 · Commercial53Original policy ↗
Premenstrual Syndrome and Premenstrual Dysphoric Disorder0512 · Commercial69Original policy ↗
Alopecia Areata0423 · Commercial72Original policy ↗
Facial Nerve Paralysis0745 · Commercial73Original policy ↗
Spasticity Management0362 · Commercial79Original policy ↗
Post-Herpetic Neuralgia0725 · Commercial87Original policy ↗
Tinnitus Treatments0406 · Commercial87Original policy ↗
Trigeminal Neuralgia: Treatments0374 · Commercial88Original policy ↗
Complementary and Alternative Medicine0388 · Commercial90Original policy ↗
0729-Diabetic Neuropathy: Selected Treatments0729 · Commercial94Original policy ↗
0788-Alzheimer's Disease: Experimental, Investigational, or Unproven Treatment0788 · Commercial95Original policy ↗
0038-Allergy and Hypersensitivity0038 · Commercial96Original policy ↗
Eating Disorders0511 · Commercial111Original policy ↗
Erectile Dysfunction and Peyronie's Disease0007 · Commercial111Original policy ↗
Urinary Incontinence0223 · Commercial119Original policy ↗
Tourette's Syndrome0480 · Commercial124Original policy ↗
Lymphedema0069 · Commercial130Original policy ↗
Myalgic Encephalomyelitis - Chronic Fatigue Syndrome (ME/CSF)0369 · Commercial139Original policy ↗
Attention Deficit/Hyperactivity Disorder0426 · Commercial188Original policy ↗
Temporomandibular Disorders0028 · Commercial197Original policy ↗
0648-Autism Spectrum Disorders0648 · Commercial284Original policy ↗
Infertility0327 · Commercial323Original policy ↗

Back to Meritain Eldorado

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.